Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
Nottingham University Launches First-of-its-kind Equipment for Chemical Imaging of Materials, Cells & Tissues
The University of Nottingham launched unique, first-of-its-kind equipment, 3DOrbiSIMS, which allows label-free chemical imaging of materials, cells and tissues, with the potential to transform research in these areas....
Researchers Develop DNA-encoded PCSK9 Inhibitors to Regulate Cholesterol Levels in Bloodstream
The Wistar Institute researchers have developed novel synthetic DNA-encoded Monoclonal Antibodies (DMAbs) directed against PCSK9, a protein key to regulating cholesterol levels in the bloodstream....
Molecule Discovery Shows Promise for Gene Therapy for Skin Diseases
<p xss=removed>University of Birmingham scientists announced the discovery of a protein that could hold the key to novel therapies for skin problems such as psoriasis.</p> <p xss=removed>The newly discovered protein, which is a fragment of a larger molecule, called JARID2 was present to only be present in the developing embryo, where it coordinates the formation of tissues and organs.</p> <p xss=removed>JARID2 is responsible for ensuring th...
Mount Sinai Researchers Determine Significant Beta Cell Proliferation Using Combination of Pharmacologic and Genetic Inhibition
A major breakthrough in diabetes treatment has been achieved by researchers at Mount Sinai, who have combined pharmacologic and genetic inhibition to stimulate the proliferation of beta cells....
Novartis Promacta® Approved as First-Line Treatment for Severe Aplastic Anemia(SAA)
Novartis' Promacta® has received approval as the primary treatment option for Severe Aplastic Anemia (SAA) in both adults and pediatric patients aged two years and above. This approval is in combination with standard immunosuppressive therapy (IST)....
NRX-101 Represents New Class of Antidepressants to Decrease Suicidal Thoughts
<p>NeuroRx's NRX-101, the first oral drug targeting suicidal bipolar depression helps to treat severe bipolar depression with Acute Suicidal Ideation & Behavior (ASIB).</p> <p>NRX-101 is used for treatment of Severe Bipolar Depression with Acute Suicidal Ideation & Behaviour after initial stabilisation with ketamine or other effective therapy.</p> <p>NRX-101 (D-cycloserine/lurasidone fixed dose combination) is the first oral drug demon...
Researchers Design and Develop New Class of Molecules to Halt Tumors
Researchers at Stevens Institute of Technology and colleagues have designed and developed a new class of molecules that use a never-before-known mechanism that may halt or destroy breast cancer tumors....
Insmed Announces ARIKAYCE® For the Treatment of Mycobacterium Avium Complex (MAC) Lung Disease
Insmed, Inc. has unveiled ARIKAYCE® (amikacin liposome inhalation suspension) as a breakthrough treatment for Mycobacterium Avium Complex (MAC) lung disease in adult patients...
NUS and Harvard Scientists Develop Novel Drug to Treat Liver Cancer Effectively
Scientists at the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) have made a significant breakthrough in the treatment of liver cancer by developing a novel peptide drug called FFW....
Pfizer Launches Janus Kinase 3 (JAK3) Inhibitor PF-06651600
Pfizer launched its investigational oral Janus Kinase 3 (JAK3) inhibitor PF-06651600, which is used for the treatment of patients with alopecia areata. Alopecia areata is chronic autoimmune skin disease in which immune cells attack healthy hair...
